维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

7篇 您的检索式：作者名="Erasmia"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males显示文摘	Erasmia Koiliari Panos Roussos Emmanouil Pasparakis	2014	Schizophr Res2014，154，13：	1
	2	Serum Angiopoietin-2 and CRP Levels During COPD Exacerbations显示文摘	Sofia Nikolakopoulou Georgios Hillas Despina Perrea Nikolaos Tentolouris Stylianos Loukides Konstantinos Kostikas Davina Simoes Erasmia Georgakopoulou Evaggelos Vogiatzakis Dimitrios Veldekis Petros Bakakos	2014	COPD: Journal of Chronic Obstructive Pulmonary Disease2014，，1：	1
	3	Nevirapine induces growth arrest and premature senescence in human cervical carcinoma cells显示文摘	Konstantinos Stefanidis Dimitris Loutradis Leandros-Vassilios Vassiliou Vasiliki Anastasiadou Erasmia Kiapekou Vasilis Nikas Giorgos Patris Georgios Vlachos Alexandros Rodolakis Aris Antsaklis	2008	Gynecologic Oncology2008，，：	1
	4	Idiopathic thrombocytopenic purpura in childhood: Twenty?years of experience in a single center显示文摘	Eftichia Stiakaki Chryssoula Perdikogianni Christina Thomou Erasmia‐Athina Markaki Nikolaos Katzilakis Maria Tsirigotaki Maria Kalmanti	2012	Pediatrics International2012，，4：	1
	5	Late Recurrent Urinary Tract Infections May Produce Renal Allograft Scarring Even in the Absence of Symptoms or Vesicoureteric Reflux显示文摘	Peter J. Dupont Erasmia Psimenou Rozanne Lord John R. Buscombe Andrew J. Hilson Paul Sweny	2007	Transplantation2007，，3：	1
	6	Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus显示文摘The incidence of esophageal adenocarcinoma,a poor prognosis neoplasia,has risen dramatically in recent decades.Barrett’s esophagus represents the best-known risk factor for esophageal adenocarcinoma development.Non-steroidal anti-inflammatory drugs through cyclooxygenase-2 inhibition and prostaglandin metabolism regulation could control cell proliferation,increase cell apoptosis and regulate the expression of growth and angiogenic factors.Statins can achieve equivalent effects through prenylation and subsequently control of cellular signaling cascades.At present,epidemiological studies are small and underpowered.Their data could not justify either medication as a chemo-preventive agent.Population based studies have shown a 43%reduction of the odds of developing an esophageal adenocarcinoma,leaving out or stating a 25%reduction in patients consuming non-aspirin nonsteroidal antiinflammatory drugs and a 50%reduction in those patients consuming aspirin.They have also stated a 19%reduction of esophageal cancer incidence when statins have been used.Observational studies have shown that non-steroidal anti-inflammatory drugs could reduce theadenocarcinoma incidence in patients with Barrett’s esophagus by 41%,while statins could reduce the risk by 43%.The cancer preventive effect has been enhanced in those patients taking a combination of non-steroidal anti-inflammatory drugs and statins(a 74%decrease).Observational data are equivocal concerning the efficacy of non-steroidal anti-inflammatory drug subclasses.Non-steroidal anti-inflammatory drugs clearly have substantial potential for toxicity,while statins are rather safe drugs.In conclusion,both non-steroidal anti-inflammatory drugs and statins are promising chemopreventive agents and deserve further exploration with interventional studies.In the meanwhile,their use is justified only in patients with cardiovascular disease.	Panagiotis Tsibouris Erasmia Vlachou Peter Edward Thomas Isaacs	2014	World Journal of Gastrointestinal Pharmacology and Therapeutics2014，5，1：	1
	7	Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens显示文摘	Maria Roussou Efstathios Kastritis Magdalini Migkou Erasmia Psimenou Irini Grapsa Charis Matsouka Despina Barmparousi Evangelos Terpos Meletios Athanasios Dimopoulos	2008	Leukemia & Lymphoma2008，，5：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费